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11 JANUARY 1992 tion, treatment, and transfer. In 1990, 1243 patients were admitted to the cardiac care unit and 10755 patients were discharged from acute medical wards.
Thus patients with acute myocardial infarction patients constituted only one part of the duty medical registrar's heavy workload.
To minimise each of the components of inhospital delay we devised and introduced a "fast track" admission system. In other hospitals a fast track system has been devised in which patients with infarction were identified before reaching hospital by paramedic ambulance staff and staff of the emergency department.' However, as yet, systems using paramedic ambulance staff have had limited applicability. The principles of the Edinburgh fast track system were: to permit very early identification of patients with clear cut myocardial infarction; to avoid multiple assessments of patients and the concomitant delays; and to permit the cardiac care team to evaluate and treat patients in the emergency department or the cardiac care unit.
In the fast track triage system patients are selected for treatment by the cardiac care team by using predefined clinical and electrocardiographic criteria, and routine evaluation by the duty medical registrar is bypassed. The cardiac care team establishes the diagnosis and initiates thrombolytic treatment in the emergency department or the cardiac care unit. We evaluated the system's impact in the first six months after its introduction. (77) 121 (49) 80 (34) 49 (21) 7 (3) 20 (8) 27 (11) 56 (23) 22 (9) 6 (2) 0 37 (15) *Includes traumatic resuscitation, bleeding diathesis, and hypertension. suspected acute myocardial infarction over the six months from 1 February to 31 July 1990. Transfers from other units within the Royal Infirmary or from other hospitals were excluded from the analysis.
The protocol specified that all patients who clearly fulfilled the defined clinical and electrocardiographic criteria for myocardial infarction would be admitted by the fast track route and the remainder, in whom the diagnosis was uncertain, would be formally evaluated by the medical registrar. We compared the results with those obtained in the 1987-8 audit. '6 In contrast with the policy in 1987-8 there was no upper age limit to thrombolytic treatment. The appendix gives the inclusion and exclusion criteria for thrombolytic treatment during the study. The Mann-Whitney test was used to determine the significance of differences between median times.
Subjects and methods
Before the fast track system was implemented we examined the admission patterns during 1-31 January 1990 to determine whether the patterns had changed appreciably since the previous detailed audit during 1 increased inappropriate referrals to the cardiac care unit. For both the fast track and non-fast track routes over 90% ofpatients admitted with suspected infarction and given thrombolytic treatment had the diagnosis confirmed. Although nine patients given thrombolytic treatment did not show increased enzyme concentrations, in none of these did the final diagnosis involve another organ system. Failure to show increased enzyme concentrations may also reflect reperfusion and "aborted" myocardial infarction.
Maintenance of the fast track system requires coordinated training of cardiac and emergency department staff, periodic audit, and the review of data on all patients delayed more than 15 minutes in the emergency department. It necessitates 24 hour availability of the cardiac care team. Our fast track system has the advantage ofnot requiring all junior emergency department staff to be familiar with the inclusion and exclusion criteria for thrombolysis. This is particularly relevant to those departments that have a high and regular turnover of junior medical staff. The fast track system removes patients with clear evidence of infarction from general medical assessment, and we found no evidence that the remainder of patients suffered additional delays. Indeed, patients with ambiguous features, admitted by the medical registrar, had delays reduced by 13-3% (table III) .
COMPARISON WITH OTHER STUDIES
In North America, inhospital delays of 50 to 130 minutes have been reported in major cardiac centres'3 14 and similar figures have been obtained in Europe and in Britain.23'5 Among American men entered into a large study of thrombolysis the median delay to thrombolysis was 4-9 hours and only a fifth of men were treated within two hours of onset of symptoms."9 Thus the findings in the 1987-8 audit in Edinburgh were not atypical for major cardiac centres, although unacceptable in the era of thrombolysis. In our present study the median times from onset of symptoms to thrombolysis were 2-5 hours for fast track patients and 3-6 hours for other patients.
Would thrombolysis before reaching hospital provide a feasible alternative for minimising delay? In the Seattle experience there was a potential time saving of about 60 minutes, but only 4% of patients with suspected myocardial infarction were eligible for treatment before arriving at hospital.20 In that study thrombolysis was administered in hospital, a median of 1-9 hours after onset of symptoms. The large scale European study (EMIP) is randomising patients before hospital and inhospital treatment by using mobile intensive care units staffed by doctors and has reported a time gain of about 60 minutes when treatment is given before reaching hospital but a median delay of 2-2 hours from symptom onset (comparable with the delay with inhospital treatment in our study).2' An alternative strategy would be direct access to the cardiac care unit, but this requires sufficient beds to admit patients to rule out infarction and a suitable triage area for managing patients with non-cardiac conditions. 22 Our study shows that changes in hospital practice can substantially reduce the delay to thrombolysis. Studies of thrombolysis treatment before patients reach hospital should therefore be compared with optimal rather than historical inhospital treatment. Our study was conducted during a period of heavy clinical demand and restricted bed availability, and the findings cannot be regarded as reflecting optimal treatment. Further reductions might be achieved if thrombolytic treatment could be started in the emergency department with minimal delay. In our hospital emergency priorities and availability of space have restricted the application of thrombolysis in the emergency department. Bolus administration systems may obviate this problem.
Although simple in design, the fast track system necessitated a change in working practice for the emergency department, the cardiac care unit, five acute medical receiving units, and the technical and paramedical staff. The system could not have been implemented if the senior house officer in the cardiac care unit had shared responsibility for other aspects of care. The main time savings achieved with the fast track system are a consequence of a clear, fully implemented policy which avoids duplicate assessments and which identifies patients with a high probability of acute infarction. The fast track system may be useful in other regional cardiac centres and district general hospitals.
Introduction
The irritable bowel syndrome is the commonest functional gastrointestinal disorder seen in both primary and secondary care,'2 and studies have shown that symptom complexes compatible with the clinical diagnosis of irritable bowel syndrome may be present in up to 30% of the general population.34 Most people with gastrointestinal symptoms never consult doctors about them5; previous studies on dyspepsia, for example, have shown that concern about the possible serious significance ofsymptoms is a major determinant of consultation behaviour.6 This is likely to be true for irritable bowel syndrome also.
Traditionally, irritable bowel syndrome has been a diagnosis of exclusion, made only after organic disease has been ruled out by investigation. Unnecessary investigations not only involve costs to the health services but also may increase diagnostic uncertainty and heighten patients' anxiety. In an attempt at greater precision, Manning and his coworkers reported the prevalence of 15 symptoms in irritable bowel syndrome and compared these with symptoms in patients with organic disease.7 They concluded that six cardinal symptoms discriminated the painful variant ofirritable bowel syndrome from organic bowel disease. The more of these six symptoms that were present, the more likely it was that the patients had irritable bowel syndrome. Subsequently Thompson examined the discriminatory value of four symptoms-abdominal pain relieved by defecation, abdominal distension, and both looser and more frequent bowel movements with the onset of pain -and concluded that if two or more of these symptoms are present irritable bowel syndrome could be discriminated from peptic ulcer or organic bowel disease.8 Talley and colleagues have evaluated the reliability and discriminatory value of the Manning criteria in irritable bowel syndrome by using an objective self report questionnaire.9 Their findings suggest that these criteria can discriminate subjects with all forms of the syndrome from healthy controls and also from patients with organic gastrointestinal disease, although a recent study has cast some doubt on the diagnostic utility of the Manning criteria in men. '0 There is also interesting evidence of disease associations with irritable bowel syndrome. A substantial number of patients also have abnormalities of bladder detrusor muscle function," and asssociations with a variety of urinary and gynaecological symptoms and with headache have been noted.'2"3 Most recently, patients with irritable bowel syndrome and without respiratory symptoms have been shown to have abnormally responsive airways after methacholine challenge, compared with normal controls and patients with organic bowel disease.'4 The possibility that a generalised smooth muscle abnormality underlies all these conditions is a subject of considerable research and potential therapeutic interest.
Irritable bowel symptoms are common in the general population and in patients with organic disease,'5 and the predictive value of any criteria will vary according to the prevalence of the disease in the population being assessed. Most people with symptoms will not present for medical care and it is possible that the symptomatology of presenting and non-presenting patients is different.34 Heaton's group, for example, has recently reported more severe abnormalities of bowel function, as well as more severe pain, in outpatients with irritable bowel syndrome compared with subjects with symptoms of irritable bowel syndrome identified in a community survey who had not sought medical attention.'6 Other reports, however, have suggested that it is more likely that sociocultural factors, rather than the type or severity of symptoms, lead to differential health seeking behaviour in those suffering from irritable bowel syndrome, '7-20 
